Ruxience 100 mg/10 ml
Ruxience 100 mg/10 ml is a medicine authorised by Swissmedic under authorisation number 69701. The authorisation holder is Pfizer AG. The medicinal product code is Biotechnological medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 19 August 2024 and the authorisation is limited until 18 August 2029. ATC code L01FA01 places the medicine in the group Antineoplastic agents.
| Authorisation number | 69701 |
|---|---|
| Name | Ruxience 100 mg/10 ml |
| Full name | Ruxience 100 mg/10 ml, Konzentrat zur Herstellung einer Infusionslösung |
| Authorisation holder | Pfizer AG |
| Medicinal product code | Biotechnological medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | L01FA01 |
| First authorisation | 19 August 2024 |
| Authorisation validity | 18 August 2029 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Ruxience 100 mg/10 ml, Konzentrat zur Herstellung einer Infusionslösung | A | 19 August 2024 |
| 2 | Ruxience 500 mg/50 ml, Konzentrat zur Herstellung einer Infusionslösung | A | 19 August 2024 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Durchstechflasche(n) | L01FA01 | 07.16.1. | A |
| 3 | 2 x 1 | Durchstechflasche(n) | L01FA01 | 07.16.1. | A |
| 2 | 1 | Durchstechflasche(n) | L01FA01 | 07.16.1. | A |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Ruxience 100 mg/10 ml authorised in Switzerland?
Yes. Ruxience 100 mg/10 ml is authorised by Swissmedic under authorisation number 69701, data as of 01 September 2026. The authorisation is limited until 18 August 2029.
Which dispensing category does Ruxience 100 mg/10 ml have?
Ruxience 100 mg/10 ml is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Ruxience 100 mg/10 ml?
The authorisation holder is Pfizer AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.